Drug Approval | August 18, 2023
The inspection closed with the facility receiving an inspection classification of NAI
The USFDA had classified Strides Puducherry facility as OAI in May 2019 followed by issuing a warning letter to this site in July 2019.
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
The new team members, Solenn Percelay and Noémie Spinelli, will support the organization’s commitment to excellence in humanized mouse model care and use
With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes
The company is excited about the strategic progress that the company has made so far and are confident of delivering better business outcomes
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
Subscribe To Our Newsletter & Stay Updated
